| Name | Cirevetmab |
|---|
| Description | Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, anti-[Canis lupus familiaris TGFB1], caninized monoclonal antibody. Cirevetmab is an immunomodulator[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |